Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7711238

CN[C@H](Cc1ccccc1)C(=O)N1CCCC1C(=O)NCc1ccc2c(N)nccc2c1.O=C(O)C(F)(F)F

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
F11 P03951 13/20 0.68
F2 P00734 9/20 0.68
F10 P00742 6/20 0.47
PRSS1 P07477 6/20 0.47
PRSS2 P07478 6/20 0.47
F7 P08709 6/20 0.47
PRSS3 P35030 6/20 0.47
F12 P00748 3/20 0.46
F9 P00740 1/20 0.46
XIAP P98170 3/20 0.46
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
PKM P14618 1/20 0.45
CYP2C19 P33261 1/20 0.45
ALDH1A1 P00352 1/20 0.45
TAAR1 Q96RJ0 1/20 0.44
KLKB1 P03952 1/20 0.44
KLK1 P06870 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6437278 1.00 F11 (0.68) F11F2F10PRSS1PRSS2
Trifluoroacetic Acid SCHEMBL3765593 0.91 F11 (0.63) F11F2F10PRSS1PRSS2
SCHEMBL6438939 0.88 F11 (0.62) F11F2PRSS1
SCHEMBL6438941 0.88 F11 (0.62) F11F2PRSS1
SCHEMBL3767038 0.87 F11 (0.65) F11F2F10PRSS1PRSS2
SCHEMBL6438340 0.87 F11 (0.65) F11F2F10PRSS1PRSS2
SCHEMBL7147704 0.87 F11 (0.69) F11F2F10PRSS1PRSS2
SCHEMBL6438235 0.86 F11 (0.61) F11F2F10PRSS1PRSS2
SCHEMBL6438232 0.86 F11 (0.61) F11F2F10PRSS1PRSS2
SCHEMBL7702655 0.86 F11 (0.65) F11F2F10PRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6444672-B1 ORAL BIOVAILABILITY; INHIBITORS OF THROMBIN AND/OR FACTOR XA; SERINE PROTEASE INHIBITOR AKZO NOBEL N.V. (NL) 2002-09-03 US disclosed